April 2, 2024
Takeda Pharmaceutical said on April 1 that it will sell its entire stake in Nihon Pharmaceutical, the company’s wholly owned subsidiary operating contract manufacturing businesses for drugs and quasi-drugs, to Alinamin Pharmaceutical for an undisclosed sum. The handover of shares...read more